In patients hospitalised for COVID-19 with clinical hypoxia who required either no
oxygen or simple oxygen only, higher dose corticosteroids significantly increased
the risk of death compared with usual care, which included low-dose corticosteroids.
The RECOVERY trial continues to assess the effects of higher dose corticosteroids
in patients hospitalised with COVID-19 who require non-invasive ventilation, invasive
mechanical ventilation, or extracorporeal membrane oxygenation.
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.